Warm Springs Advisors Inc. Buys 5,000 Shares of Intuitive Surgical, Inc. $ISRG

Warm Springs Advisors Inc. grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 231.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,160 shares of the medical equipment provider’s stock after purchasing an additional 5,000 shares during the period. Intuitive Surgical makes up 2.4% of Warm Springs Advisors Inc.’s investment portfolio, making the stock its 16th largest holding. Warm Springs Advisors Inc.’s holdings in Intuitive Surgical were worth $3,202,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Tobam lifted its holdings in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares during the period. Kilter Group LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $27,000. Greykasell Wealth Strategies Inc. bought a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $27,000. Guerra Advisors Inc purchased a new position in shares of Intuitive Surgical in the 3rd quarter valued at approximately $37,000. Finally, Riggs Asset Managment Co. Inc. boosted its position in shares of Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after purchasing an additional 32 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $506.88 on Friday. The company has a market capitalization of $180.01 billion, a price-to-earnings ratio of 64.24, a price-to-earnings-growth ratio of 3.90 and a beta of 1.65. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $603.88. The company’s 50-day moving average is $531.21 and its 200 day moving average is $511.26.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the prior year, the firm posted $2.21 earnings per share. The business’s revenue was up 18.8% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on ISRG shares. Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 19th. Piper Sandler reiterated an “overweight” rating and issued a $620.00 price target (up from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Evercore lowered their price target on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating for the company in a research report on Friday, January 23rd. Argus cut their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a report on Wednesday, February 4th. Finally, Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $615.86.

Insider Activity

In related news, Director Gary S. Guthart sold 24,500 shares of the company’s stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the transaction, the director directly owned 3,694 shares of the company’s stock, valued at approximately $1,958,189.40. This represents a 86.90% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the sale, the vice president directly owned 660 shares of the company’s stock, valued at approximately $326,673.60. The trade was a 16.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 56,189 shares of company stock valued at $30,785,441 in the last quarter. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.